SELLAS Life Sciences (SLS) Deferred Taxes (2013 - 2019)
SELLAS Life Sciences (SLS) posted quarterly Deferred Taxes of -$95000.0 for Q4 2019, up 93.04% year-over-year from -$49212.5 in Q4 2018, and up 93.04% quarter-over-quarter from -$1.4 million in Q4 2018.
SELLAS Life Sciences (SLS) Deferred Taxes (2013 - 2019) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Deferred Taxes for 4 consecutive years, with -$95000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Deferred Taxes rose 93.04% year-over-year to -$95000.0; the TTM figure through Dec 2019 stood at -$1.5 million (down 7.04% YoY), while the FY2021 annual figure was -$239000.0, down 939.13% from the prior year.
- Deferred Taxes grew to -$95000.0 in Q4 2019 per SLS's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $1000.0 in Q3 2017 and bottomed at -$1.4 million in Q4 2018.
- Historically, Deferred Taxes has averaged -$486333.3 across 3 years, with a median of -$95000.0 in 2019.
- On a YoY basis, Deferred Taxes climbed as much as 93.04% in 2019 and fell as far as 93.04% in 2019.
- SELLAS Life Sciences' Deferred Taxes stood at $1000.0 in 2017, then sank by 136600.0% to -$1.4 million in 2018, then surged by 93.04% to -$95000.0 in 2019.
- Business Quant data shows SLS's Deferred Taxes at -$95000.0 in Q4 2019, -$1.4 million in Q4 2018, and $1000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -95,000.00 |
| Dec 31, 2018 | -1.37 Mn |
| Sep 30, 2017 | 1,000.00 |
| Dec 31, 2013 | 1.12 Mn |
| Sep 30, 2013 | 1.16 Mn |
| Jun 30, 2013 | 1.54 Mn |
| Mar 31, 2013 | -2.76 Mn |